By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accipiter Life Sciences Fund last week informed Orchid Cellmark that it will nominate three individuals to serve on the DNA testing company's board of directors — a move that would effectively replace the three Class I directors of the current board, according to a filing with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.